Press Releases
Samsung BIO Insight
Building a Sustainable Future from the Ground Up
Bio Campus II, the future location of Plants 5-8
While the world continues to face mounting pressure to
alter the trajectory of global warming, many companies are taking concerted climate action toward reducing
their carbon footprint and implementing more sustainable practices. As part of our mission to build a more
sustainable future for all, Samsung Biologics is adopting systems that reduce energy consumption and recycle
waste throughout our current and future plants.
“As we continue to expand our capacity, we knew it was
imperative that any new plants we built would now seriously impact our net-zero transition by 2050 or
earlier,” said Hyeonsoo Min, Lead Engineer in the Plant 5 Task Force. “That’s why when designing Plant 5, we
really tried to think outside the box on how we could bring this plant online without compromising our
Scopes 1* and 2*
emission reduction goals.”
* Scope 1: All direct emissions
from activities of the company and under the control of Samsung Biologics.
* Scope 2: Indirect emissions
created through purchased energy and used by Samsung Biologics for company operations.
Embracing a low-carbon design
When designing our new Plant 5, the Samsung Biologics
team took a low-carbon approach by optimizing all energy sources and choosing recyclable building materials,
including high-performance insulation that significantly reduces energy consumption. Once it becomes
operational in April 2025, Plant 5 will use nearly 20% renewable energy across all operations, and it is
expected to reduce the company’s carbon footprint by nearly 20% compared to its existing plants.
In terms of the building’s infrastructure, Samsung
Biologics plans to use low-carbon green concrete, which contains 50% less carbon than traditional concrete,
on 15,000㎡ of the total Bio
Campus II. A megawatt-hour (MWh) solar power generator will be installed on the plant’s roof to save more
than 1,163 MWh in a year.
Besides a reverse osmosis (RO) water treatment system,
which reuses the wastewater generated from manufacturing water for injection (WFI), sustainable operation
systems using geothermal power and municipal hot water have also been implemented into the facility’s
structure, with the benefit of reducing over 11,000 tCO2eq of GHG emissions as well as operating
costs.
“Plant 5 is designed to facilitate the transition to
renewable energy from construction to future operations and to achieve our net-zero goal. We will continue
our efforts to increase on-site renewable energy generation,” Min explained.
Paving the way for a greener future
Samsung Biologics recently published its annual ESG
report, reflecting the company’s latest sustainability efforts. As part of the company’s mission to deliver
net zero by 2050 or earlier, Samsung Biologics established new milestones: to cut 32% of Scope 1 and 2
emissions by 2030 and 62% by 2040.
In April this year, Samsung Biologics established an
enhanced recycling area in Bio Campus I called the Green Center, aiming to achieve an 80% recycling rate.
This facility will also be added to future manufacturing sites. The company introduced RFID technology to
improve medical waste management efficiency by automatically identifying and tracking hazardous medical
waste.
“With these sustainable practices, we are further
strengthening our commitment to energy efficiency, renewable energy, and the reduction of our environmental
footprint. We are taking steps toward a greener future while reducing costs and generating positive
savings,” Min said.
As a leading sustainable CDMO partner, Samsung Biologics
understands the seriousness of climate change and its impact on public health; therefore, we are stepping up
to the challenge of leading our industry toward a more sustainable future.
“Just as our partners trust us to deliver the highest
quality biomedicines, we are committed to building on that foundation to deliver sustainable outcomes,” he
added.
Driven. For a
Sustainable Life.
Related contents
Bio Campus II, the future location of Plants 5-8
While the world continues to face mounting pressure to
alter the trajectory of global warming, many companies are taking concerted climate action toward reducing their
carbon footprint and implementing more sustainable practices. As part of our mission to build a more sustainable
future for all, Samsung Biologics is adopting systems that reduce energy consumption and recycle waste
throughout our current and future plants.
“As we continue to expand our capacity, we knew it was
imperative that any new plants we built would now seriously impact our net-zero transition by 2050 or earlier,”
said Hyeonsoo Min, Lead Engineer in the Plant 5 Task Force. “That’s why when designing Plant 5, we really tried
to think outside the box on how we could bring this plant online without compromising our Scopes 1* and 2* emission
reduction goals.”
* Scope 1: All direct emissions
from activities of the company and under the control of Samsung Biologics.
* Scope 2: Indirect emissions
created through purchased energy and used by Samsung Biologics for company operations.
Embracing a low-carbon design
When designing our new Plant 5, the Samsung Biologics team
took a low-carbon approach by optimizing all energy sources and choosing recyclable building materials,
including high-performance insulation that significantly reduces energy consumption. Once it becomes operational
in April 2025, Plant 5 will use nearly 20% renewable energy across all operations, and it is expected to reduce
the company’s carbon footprint by nearly 20% compared to its existing plants.
In terms of the building’s infrastructure, Samsung
Biologics plans to use low-carbon green concrete, which contains 50% less carbon than traditional concrete, on
15,000㎡ of the total Bio
Campus II. A megawatt-hour (MWh) solar power generator will be installed on the plant’s roof to save more than
1,163 MWh in a year.
Besides a reverse osmosis (RO) water treatment system,
which reuses the wastewater generated from manufacturing water for injection (WFI), sustainable operation
systems using geothermal power and municipal hot water have also been implemented into the facility’s structure,
with the benefit of reducing over 11,000 tCO2eq of GHG emissions as well as operating costs.
“Plant 5 is designed to facilitate the transition to
renewable energy from construction to future operations and to achieve our net-zero goal. We will continue our
efforts to increase on-site renewable energy generation,” Min explained.
Paving the way for a greener future
Samsung Biologics recently published its annual ESG
report, reflecting the company’s latest sustainability efforts. As part of the company’s mission to deliver net
zero by 2050 or earlier, Samsung Biologics established new milestones: to cut 32% of Scope 1 and 2 emissions by
2030 and 62% by 2040.
In April this year, Samsung Biologics established an
enhanced recycling area in Bio Campus I called the Green Center, aiming to achieve an 80% recycling rate. This
facility will also be added to future manufacturing sites. The company introduced RFID technology to improve
medical waste management efficiency by automatically identifying and tracking hazardous medical waste.
“With these sustainable practices, we are further
strengthening our commitment to energy efficiency, renewable energy, and the reduction of our environmental
footprint. We are taking steps toward a greener future while reducing costs and generating positive savings,”
Min said.
As a leading sustainable CDMO partner, Samsung Biologics
understands the seriousness of climate change and its impact on public health; therefore, we are stepping up to
the challenge of leading our industry toward a more sustainable future.
“Just as our partners trust us to deliver the highest
quality biomedicines, we are committed to building on that foundation to deliver sustainable outcomes,” he
added.
Driven. For a
Sustainable Life.
Related contents